Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

UV light absorption parameters of the pathobiologically implicated bilirubin oxidation products, MVM, BOX A, and BOX B.

Harris NA, Rapoport RM, Zuccarello M, Maggio JE.

Data Brief. 2018 Apr 12;18:1400-1409. doi: 10.1016/j.dib.2018.04.010. eCollection 2018 Jun.

2.

Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity.

Welzel AT, Maggio JE, Shankar GM, Walker DE, Ostaszewski BL, Li S, Klyubin I, Rowan MJ, Seubert P, Walsh DM, Selkoe DJ.

Biochemistry. 2014 Jun 24;53(24):3908-21.

3.

Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer.

Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, Mukherjee P, Maggio JE, Mantyh PW.

Gastroenterology. 2006 Sep;131(3):900-10.

4.

Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.

Chu G, Kerr JP, Mitton B, Egnaczyk GF, Vazquez JA, Shen M, Kilby GW, Stevenson TI, Maggio JE, Vockley J, Rapundalo ST, Kranias EG.

FASEB J. 2004 Nov;18(14):1725-7. Epub 2004 Sep 9.

PMID:
15358683
5.

Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20.

Chu G, Egnaczyk GF, Zhao W, Jo SH, Fan GC, Maggio JE, Xiao RP, Kranias EG.

Circ Res. 2004 Feb 6;94(2):184-93. Epub 2003 Nov 13.

PMID:
14615292
6.

Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure.

Egnaczyk GF, Pomonis JD, Schmidt JA, Rogers SD, Peters C, Ghilardi JR, Mantyh PW, Maggio JE.

Proteomics. 2003 May;3(5):689-98.

PMID:
12748948
7.

Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis.

Peters CM, Rogers SD, Pomonis JD, Egnaczyk GF, Keyser CP, Schmidt JA, Ghilardi JR, Maggio JE, Mantyh PW.

Exp Neurol. 2003 Mar;180(1):1-13. Erratum in: Exp Neurol. 2003 Aug;182(2):518. Egnazyck, Gregory F [corrected to Egnaczyk, Gregory F].

PMID:
12668144
8.

Apolipoprotein E affects amyloid formation but not amyloid growth in vitro: mechanistic implications for apoE4 enhanced amyloid burden and risk for Alzheimer's disease.

Esler WP, Marshall JR, Stimson ER, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE.

Amyloid. 2002 Mar;9(1):1-12.

PMID:
12000192
9.

Noninvasive imaging of peripherally injected Alzheimer's disease type synthetic A beta amyloid in vivo.

Marshall JR, Stimson ER, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE.

Bioconjug Chem. 2002 Mar-Apr;13(2):276-84.

PMID:
11906265
10.

Development of a novel probe for measuring drug binding to the F1*S variant of human alpha 1-acid glycoprotein.

Cogswell LP 3rd, Raines DE, Parekh S, Jonas O, Maggio JE, Strichartz GR.

J Pharm Sci. 2001 Sep;90(9):1407-23.

PMID:
11745793
11.
12.

Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid.

Esler WP, Felix AM, Stimson ER, Lachenmann MJ, Ghilardi JR, Lu YA, Vinters HV, Mantyh PW, Lee JP, Maggio JE.

J Struct Biol. 2000 Jun;130(2-3):174-83.

PMID:
10940224
13.

The Alzheimer's peptide a beta adopts a collapsed coil structure in water.

Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, Lu Y, Felix AM, Maggio JE, Lee JP.

J Struct Biol. 2000 Jun;130(2-3):130-41.

PMID:
10940221
14.

Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.

Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, Lee JP, Mantyh PW, Maggio JE.

Biochemistry. 2000 May 30;39(21):6288-95.

PMID:
10828941
15.

Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors.

Esler WP, Stimson ER, Mantyh PW, Maggio JE.

Methods Enzymol. 1999;309:350-74. No abstract available.

PMID:
10507035
16.

Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.

Tseng BP, Esler WP, Clish CB, Stimson ER, Ghilardi JR, Vinters HV, Mantyh PW, Lee JP, Maggio JE.

Biochemistry. 1999 Aug 10;38(32):10424-31.

PMID:
10441137
17.

Stereochemical specificity of Alzheimer's disease beta-peptide assembly.

Esler WP, Stimson ER, Fishman JB, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE.

Biopolymers. 1999 May;49(6):505-14.

PMID:
10193196
18.

Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42).

O'Hare E, Weldon DT, Mantyh PW, Ghilardi JR, Finke MP, Kuskowski MA, Maggio JE, Shephard RA, Cleary J.

Brain Res. 1999 Jan 2;815(1):1-10.

PMID:
9974116
19.

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, Esler WP, Maggio JE, Mantyh PW.

J Neurosci. 1998 Mar 15;18(6):2161-73. Review.

20.

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

Podlisny MB, Walsh DM, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB, Selkoe DJ.

Biochemistry. 1998 Mar 17;37(11):3602-11.

PMID:
9521679
21.

New insights into the neuropathology and cell biology of Alzheimer's disease.

Weldon DT, Maggio JE, Mantyh PW.

Geriatrics. 1997 Sep;52 Suppl 2:S13-6. Review.

PMID:
9307579
22.

Expression of endothelin-B receptors by glia in vivo is increased after CNS injury in rats, rabbits, and humans.

Rogers SD, Demaster E, Catton M, Ghilardi JR, Levin LA, Maggio JE, Mantyh PW.

Exp Neurol. 1997 May;145(1):180-95.

PMID:
9184120
23.
24.

A beta deposition inhibitor screen using synthetic amyloid.

Esler WP, Stimson ER, Ghilardi JR, Felix AM, Lu YA, Vinters HV, Mantyh PW, Maggio JE.

Nat Biotechnol. 1997 Mar;15(3):258-63.

PMID:
9062926
25.

Absorption and excretion of undegradable peptides: role of lipid solubility and net charge.

Pappenheimer JR, Karnovsky ML, Maggio JE.

J Pharmacol Exp Ther. 1997 Jan;280(1):292-300.

PMID:
8996209
26.

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma.

Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ.

J Biol Chem. 1996 Dec 20;271(51):32916-22.

27.

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence.

Esler WP, Stimson ER, Ghilardi JR, Lu YA, Felix AM, Vinters HV, Mantyh PW, Lee JP, Maggio JE.

Biochemistry. 1996 Nov 5;35(44):13914-21.

PMID:
8909288
28.

Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo.

Ghilardi JR, Catton M, Stimson ER, Rogers S, Walker LC, Maggio JE, Mantyh PW.

Neuroreport. 1996 Nov 4;7(15-17):2607-11.

PMID:
8981432
29.

Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo.

Mantyh PW, Rogers SD, Ghilardi JR, Maggio JE, Mantyh CR, Vigna SR.

Brain Res. 1996 May 6;719(1-2):8-13.

PMID:
8782857
30.

Brain amyloid--a physicochemical perspective.

Maggio JE, Mantyh PW.

Brain Pathol. 1996 Apr;6(2):147-62. Review.

PMID:
8737930
31.

Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis.

Mantyh CR, Maggio JE, Mantyh PW, Vigna SR, Pappas TN.

Dig Dis Sci. 1996 Mar;41(3):614-20. Review.

PMID:
8617145
32.

Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro.

Esler WP, Stimson ER, Jennings JM, Ghilardi JR, Mantyh PW, Maggio JE.

J Neurochem. 1996 Feb;66(2):723-32.

PMID:
8592145
33.

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

Esler WP, Stimson ER, Ghilardi JR, Vinters HV, Lee JP, Mantyh PW, Maggio JE.

Biochemistry. 1996 Jan 23;35(3):749-57.

PMID:
8547255
34.

Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis.

Mantyh CR, Vigna SR, Bollinger RR, Mantyh PW, Maggio JE, Pappas TN.

Gastroenterology. 1995 Sep;109(3):850-60.

PMID:
7657114
35.

Zinc and Alzheimer's disease.

Maggio JE, Esler WP, Stimson ER, Jennings JM, Ghilardi JR, Mantyh PW.

Science. 1995 Jun 30;268(5219):1920-1; author reply 1921-3. No abstract available.

PMID:
7604269
36.

Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation.

Mantyh PW, DeMaster E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE, et al.

Science. 1995 Jun 16;268(5217):1629-32.

PMID:
7539937
37.

Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis.

Brown JL, Liu H, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI.

J Comp Neurol. 1995 Jun 5;356(3):327-44.

PMID:
7642798
38.

Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo.

Mantyh PW, Allen CJ, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2622-6.

39.

Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists.

Li YM, Marnerakis M, Stimson ER, Maggio JE.

J Biol Chem. 1995 Jan 20;270(3):1213-20.

40.

Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human.

Mantyh PW, Rogers SD, Allen CJ, Catton MD, Ghilardi JR, Levin LA, Maggio JE, Vigna SR.

J Neurosci. 1995 Jan;15(1 Pt 1):152-64.

41.
42.

Local anesthetics inhibit substance P binding and evoked increases in intracellular Ca2+.

Li YM, Wingrove DE, Too HP, Marnerakis M, Stimson ER, Strichartz GR, Maggio JE.

Anesthesiology. 1995 Jan;82(1):166-73.

PMID:
7530414
44.

Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors.

Mantyh CR, Vigna SR, Maggio JE, Mantyh PW, Bollinger RR, Pappas TN.

Neurosci Lett. 1994 Sep 12;178(2):255-9.

PMID:
7529913
45.

Intestinal absorption and excretion of octapeptides composed of D amino acids.

Pappenheimer JR, Dahl CE, Karnovsky ML, Maggio JE.

Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1942-5.

46.
47.

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE.

J Neurochem. 1993 Sep;61(3):1171-4.

PMID:
8360682
48.

Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization.

Allen CJ, Ghilardi JR, Vigna SR, Mannon PJ, Taylor IL, McVey DC, Maggio JE, Mantyh PW.

Neuroscience. 1993 Apr;53(3):889-98.

PMID:
7683778
49.

Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion.

DeBin JA, Maggio JE, Strichartz GR.

Am J Physiol. 1993 Feb;264(2 Pt 1):C361-9.

PMID:
8383429
50.

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.

Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW.

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5462-6.

Supplemental Content

Loading ...
Support Center